Driven by science,
committed to sustainability
We enable chemical industries to become major players in the path towards a more sustainable, nature friendly and efficient economy
Sustainable development goals (SDGs)
We care about the future.
As 2015 drew to a close, the United Nations acknowledged the conclusion of the 15-year cycle of the anti-poverty Millennium Development Goals (MDGs). Looking ahead to 1st January 2016, they launched a far more ambitious agenda, aiming to eradicate a wide range of social challenges by 2030.
​
inSEIT is commited to the Sustainable Development Goals (SDGs) by promoting sustainable practices throughout its services and products. We prioritize resource efficiency and reduced emissions in our catalytic offerings, contributing to a more sustainable and equitable future.
See what we do - and how we do it
Team
David Roura Padrosa, PhD
CEO and Co-founder
Committed to green chemistry and enzymes' future. He graduated with honors from the University of Girona and pursued a PhD in chemical biology in the UK. His research on enzyme immobilization showed that, combined with bioinformatics tools, it can transform industrial biocatalysis.
Gordon Honeyman, PhD
COO and Co-founder
PhD chemist in Polymer Organometallic Chemistry from the University Strathclyde, Glasgow. He worked in both SMEs and start-ups in the UK chemical medical device industry for over 10 years, and became the lab manager at the Paradisi group in Switzerland in 2019, specializing in enzyme immobilization.
_edited_edited_edited.jpg)
Cristina Lía Fernández Regueiro, PhD
R&D Project Manager
Lia is intrigued by enzymes and sees nature as vital innovation. A material chemist with experience in enzyme technologies and biosensing. After her PhD at the Huck group, she significantly contributed to the development of Indicate Biotech, transforming virus detection.
Board of directors
Prof. Francesca Paradisi
Co-founder and Key Scientific Advisor
Prof. Paradisi is a leader in applied biocatalysis, merging her chemistry expertise with biocatalysis and continuous flow. Her lab has showcased flow-biocatalysis for creating valuable chemicals, with enzyme immobilization as a key enabling technology for biocatalytic applications.
_edited.jpg)
Prof. Walter Cabri
Board member
Prof. Cabri, who has more than 25 years of experience in the chemical industry, was a pioneer in the use of enzyme applications for chemical production. He possesses over 100 patents and has showcased the effectiveness of biocatalysis for efficient and most importantly, green chemical synthesis.
Dr. Theresa Visarius
Board member
Dr. Visarius is a visionary entrepreneur and former academic at the University of Bern, she currently serves as the VP of Business Development at Immunophotonics. She coaches promising Swiss start-ups in the medtech and biotech sectors, leveraging her expertise in business scaling and fundraising.
Board of advisors
Prof. Fernando López-Gallego
Co-founder and Key Scientific Advisor
Dr. Fernando López-Gallego, an IKERBASQUE research professor at CICbiomaGUNE in San Sebastián, Spain, leads the heterogeneous biocatalysis group. He specializes in utilizing multienzyme systems in biotechnological processes, leveraging the selectivity of enzymes.
Dr. Fabrice Gallou
Board member
Dr. Gallou is a Distinguished Scientist at Novartis Pharma, specializing in process research and development. He excels in strategic vision, driving change, and continuous improvement. Currently, he ensures efficient and sustainable syntheses for all APIs.
Dr. Marc Garcia-Borràs
Bioinformatics advisor
Dr. Garcia-Borràs leads a research group at the IQCC (Institut de Química Computacional i Catà) at the University of Girona. He specializes in using advanced bioinformatic tools to model enzyme reactivity, understanding their catalytic properties and guiding forces.